Suppr超能文献

非洛地平治疗高血压的获益-风险平衡相关方面

Aspects on the benefit-risk balance of felodipine in hypertension.

作者信息

Elmfeldt D, Westerling S

机构信息

Medical Department, Cardiovascular Research, AB Hässle, Mölndal.

出版信息

Drugs. 1987;34 Suppl 3:132-5. doi: 10.2165/00003495-198700343-00028.

Abstract

This review attempts to evaluate the benefit-risk balance of felodipine in the treatment of hypertension. Known positive and negative properties of felodipine are considered. Although accurate benefit-risk statements may be difficult even for old, well-established drugs it is concluded that felodipine appears to be an effective and well tolerated new antihypertensive drug. The reduction in blood pressure during felodipine treatment has been superior to that seen with established antihypertensive drugs in controlled studies.

摘要

本综述旨在评估非洛地平治疗高血压的获益-风险平衡。文中考虑了非洛地平已知的阳性和阴性特性。尽管即便对于使用已久的成熟药物,准确阐述其获益-风险情况也可能存在困难,但得出的结论是,非洛地平似乎是一种有效且耐受性良好的新型抗高血压药物。在对照研究中,非洛地平治疗期间的血压降低幅度优于已有的抗高血压药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验